Press release
Aneurysmal Subarachnoid Hemorrhage Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, NDA Approval, Therapies, ROA, MOA and Companies by DelveInsight
Aneurysmal Subarachnoid Hemorrhage Market
To Know in detail about the Aneurysmal Subarachnoid Hemorrhage market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Aneurysmal Subarachnoid Hemorrhage Market Forecast
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Aneurysmal Subarachnoid Hemorrhage Market Report:
• The Aneurysmal Subarachnoid Hemorrhage market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In May 2023, Acasti Pharma disclosed the submission of the GTX-104's comprehensive protocol for its crucial Phase III safety investigation to the FDA. Concurrently, the company has initiated a strategic realignment initiative aimed at optimizing shareholder value.
• In October 2022, Aspen Healthcare has recently forged an exclusive licensing deal with Brain Implant Therapeutics (BIT) Pharma for a Nicardipine-based intracerebral implant designed to mitigate vasospasm, a postoperative complication often observed in patients undergoing subarachnoid hemorrhage surgery.
• In 2023, the United States accounted for the second-largest share of incident cases of aSAH among the 7 major markets, comprising approximately 24.5% of the total share.
• According to DelveInsight's analysis, the total number of incident cases of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the 7 major markets (7MM) was approximately 54,600 cases in 2023.
• In 2023, Japan recorded the highest incident population of Aneurysmal Subarachnoid Hemorrhage (aSAH), with approximately 32,000 cases.
• According to a study by Ziu et al. (2023), the annual incidence of subarachnoid hemorrhage in the United States ranges from 10 to 14 cases per 100,000 individuals.
• Key Aneurysmal Subarachnoid Hemorrhage Companies: Acasti Pharma Inc., BIT Pharma, Aaron Cook, Haaglanden Medical Centre, and others
• Key Aneurysmal Subarachnoid Hemorrhage Therapies: GTX-104, NicaPlant (nicardipine), Telavancin Injection, C1 Esterase Inhibitor Injection, and others
• Subarachnoid hemorrhage (aSAH) is more prevalent in females, constituting approximately 66% of the total incident cases of aSAH.
• The Aneurysmal Subarachnoid Hemorrhage market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Aneurysmal Subarachnoid Hemorrhage pipeline products will significantly revolutionize the Aneurysmal Subarachnoid Hemorrhage market dynamics.
Aneurysmal Subarachnoid Hemorrhage Overview
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition caused by the rupture of a cerebral aneurysm, leading to bleeding in the subarachnoid space-the area between the brain and the thin tissues covering it. This accounts for approximately 85% of spontaneous subarachnoid hemorrhages and is a major cause of stroke-related death and disability.
The most common symptom of aSAH is a sudden, severe headache often described as the "worst headache of my life." Other symptoms may include nausea, vomiting, stiff neck, blurred vision, confusion, seizures, and loss of consciousness. Risk factors include hypertension, smoking, excessive alcohol consumption, genetic predisposition, and certain connective tissue disorders.
Diagnosis is confirmed through a computed tomography (CT) scan, followed by a lumbar puncture if needed. Cerebral angiography helps locate and assess the aneurysm. Immediate treatment is crucial to prevent rebleeding and secondary complications such as vasospasm and hydrocephalus.
Treatment options include surgical clipping and endovascular coiling, both aimed at securing the aneurysm to prevent further bleeding. Supportive care in an intensive care unit (ICU), blood pressure control, and medications like nimodipine to prevent vasospasm are critical for improving outcomes. Despite advances in treatment, aSAH carries a high mortality and morbidity risk.
Get a Free sample for the Aneurysmal Subarachnoid Hemorrhage Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Aneurysmal Subarachnoid Hemorrhage Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Aneurysmal Subarachnoid Hemorrhage Epidemiology Segmentation:
The Aneurysmal Subarachnoid Hemorrhage market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Aneurysmal Subarachnoid Hemorrhage
• Prevalent Cases of Aneurysmal Subarachnoid Hemorrhage by severity
• Gender-specific Prevalence of Aneurysmal Subarachnoid Hemorrhage
• Diagnosed Cases of Episodic and Chronic Aneurysmal Subarachnoid Hemorrhage
Download the report to understand which factors are driving Aneurysmal Subarachnoid Hemorrhage epidemiology trends @ Aneurysmal Subarachnoid Hemorrhage Epidemiology Forecast
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Aneurysmal Subarachnoid Hemorrhage Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Aneurysmal Subarachnoid Hemorrhage market or expected to get launched during the study period. The analysis covers Aneurysmal Subarachnoid Hemorrhage market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Aneurysmal Subarachnoid Hemorrhage Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Aneurysmal Subarachnoid Hemorrhage Therapies and Key Companies
• GTX-104: Acasti Pharma Inc.
• NicaPlant (nicardipine) : BIT Pharma
• Telavancin Injection: Aaron Cook
• C1 Esterase Inhibitor Injection: Haaglanden Medical Centre
Discover more about therapies set to grab major Aneurysmal Subarachnoid Hemorrhage market share @ Aneurysmal Subarachnoid Hemorrhage Treatment Landscape
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Aneurysmal Subarachnoid Hemorrhage Market Strengths
• Several trials are underway that may offer results that will further enhance the practice of the anesthesiologist and thus improve the short-term and long-term outcomes for aSAH
• The 20th century has seen a great advancement in diagnosis, starting with ability to recognize the condition at all during life.
Aneurysmal Subarachnoid Hemorrhage Market Opportunities
• Limited therapies are available for treatment aSAH; thus providing profitable opportunities for emerging therapies.
• Demands of advanced therapeutics and the presence of a significant number of pipeline drugs.
• High R&D investment and marketing outlay for innovative drugs.
Scope of the Aneurysmal Subarachnoid Hemorrhage Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Aneurysmal Subarachnoid Hemorrhage Companies: Acasti Pharma Inc., BIT Pharma, Aaron Cook, Haaglanden Medical Centre, and others
• Key Aneurysmal Subarachnoid Hemorrhage Therapies: GTX-104, NicaPlant (nicardipine), Telavancin Injection, C1 Esterase Inhibitor Injection, and others
• Aneurysmal Subarachnoid Hemorrhage Therapeutic Assessment: Aneurysmal Subarachnoid Hemorrhage current marketed and Aneurysmal Subarachnoid Hemorrhage emerging therapies
• Aneurysmal Subarachnoid Hemorrhage Market Dynamics: Aneurysmal Subarachnoid Hemorrhage market drivers and Aneurysmal Subarachnoid Hemorrhage market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Aneurysmal Subarachnoid Hemorrhage Unmet Needs, KOL's views, Analyst's views, Aneurysmal Subarachnoid Hemorrhage Market Access and Reimbursement
To know more about Aneurysmal Subarachnoid Hemorrhage companies working in the treatment market, visit @ Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Aneurysmal Subarachnoid Hemorrhage Market Report Introduction
2. Executive Summary for Aneurysmal Subarachnoid Hemorrhage
3. SWOT analysis of Aneurysmal Subarachnoid Hemorrhage
4. Aneurysmal Subarachnoid Hemorrhage Patient Share (%) Overview at a Glance
5. Aneurysmal Subarachnoid Hemorrhage Market Overview at a Glance
6. Aneurysmal Subarachnoid Hemorrhage Disease Background and Overview
7. Aneurysmal Subarachnoid Hemorrhage Epidemiology and Patient Population
8. Country-Specific Patient Population of Aneurysmal Subarachnoid Hemorrhage
9. Aneurysmal Subarachnoid Hemorrhage Current Treatment and Medical Practices
10. Aneurysmal Subarachnoid Hemorrhage Unmet Needs
11. Aneurysmal Subarachnoid Hemorrhage Emerging Therapies
12. Aneurysmal Subarachnoid Hemorrhage Market Outlook
13. Country-Wise Aneurysmal Subarachnoid Hemorrhage Market Analysis (2020-2034)
14. Aneurysmal Subarachnoid Hemorrhage Market Access and Reimbursement of Therapies
15. Aneurysmal Subarachnoid Hemorrhage Market Drivers
16. Aneurysmal Subarachnoid Hemorrhage Market Barriers
17. Aneurysmal Subarachnoid Hemorrhage Appendix
18. Aneurysmal Subarachnoid Hemorrhage Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Reports:
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Allergic Conjunctivitis Market: https://www.delveinsight.com/report-store/allergic-conjunctivitis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/neuroendocrine-tumors-market
• Diabetic Nephropathy Market: https://www.delveinsight.com/report-store/diabetic-kidney-disease-dkd-market
• Graft Versus Host Disease Market: https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-epidemiology-forecast
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Aesthetic Implants Market: https://www.delveinsight.com/blog/aesthetic-implants-market-outlook-and-key-trends
• Anal Cancer Market: https://www.delveinsight.com/report-store/anal-cancer-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market-forecast
• Neuromodulation Devices Market: https://www.delveinsight.com/report-store/neuromodulation-devices-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Walking Impairment In Multiple Sclerosis Market: https://www.delveinsight.com/report-store/walking-impairment-in-multiple-sclerosis-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-market
• Pharma Licensing Services: https://www.delveinsight.com/consulting/licensing-services
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/infusion-pumps-market
• Acute Intermittent Porphyria Market: https://www.delveinsight.com/sample-request/acute-intermittent-porphyria-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Molecular Glue Trials: https://www.delveinsight.com/report-store/molecular-glues-competitive-landscape
• Cardiorenal Syndrome Market: https://www.delveinsight.com/report-store/myocardial-infarction-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/anti-cd274-pd-l1-antibody-pipeline-insight
• Hereditary Spastic Paraplegias Market: https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
• Molecular Glue Market: https://www.delveinsight.com/report-store/molecular-glues-market-forecast
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/report-store.php
AACR Conference Coverage: https://www.delveinsight.com/aacr-annual-meeting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aneurysmal Subarachnoid Hemorrhage Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, NDA Approval, Therapies, ROA, MOA and Companies by DelveInsight here
News-ID: 3911319 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Aneurysm
Intracranial Aneurysm Market Report 2030
Intracranial aneurysms, silent yet perilous anomalies in cerebral blood vessels, present a pressing healthcare concern. With the market poised to surge from USD 1.2 billion in 2021 to USD 2.6 billion by 2030, fueled by escalating incidences and groundbreaking product introductions, addressing this medical challenge becomes imperative.
Download Sample Report Copy Of This Report From Here: https://www.amecoresearch.com/sample/276712
Key Points and Statistics:
• The Intracranial Aneurysm Market is forecasted to reach USD 2.63 billion…
Endovascular Abdominal Aortic Aneurysm Repair Devices Market - Transforming Aort …
Newark, New Castle, USA: The "Endovascular Abdominal Aortic Aneurysm Repair Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Endovascular Abdominal Aortic Aneurysm Repair Devices Market: https://www.growthplusreports.com/report/endovascular-abdominal-aortic-aneurysm-repair-devices-market/8843
This…
Aortic Aneurysm Market - Transforming the Aortic Aneurysm Landscape: Redefining …
Newark, New Castle, USA: The "Aortic Aneurysm Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Aortic Aneurysm Market: https://www.growthplusreports.com/report/aortic-aneurysm-market/8565
This latest report researches the industry structure, sales,…
Endovascular Aneurysm Repair Market Growing At A CAGR Of 6.2% And To Target $3.5 …
Advancements in endograft stent technologies and a shift from open surgical repair to minimal invasive endovascular repair has led to the sizeable market growth.
The endovascular aneurysm repair market was valued at $2.32 billion in 2016, and is projected to reach $3.58 billion by 2023, growing at a CAGR of 6.2% from 2017 to 2023. The abdominal aortic aneurysm (AAA) segment accounted for nearly seventh-ninth share of the total market in…
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient.
Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL
Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market…
A Exclusive Market Research Study on Aortic Aneurysm Repair Devices Market| By A …
This Report by Worldwide Market Reports on Smart City ICT Infrastructure is a detailed analysis of the market providing you with the latest industry data and future market trends. The details and data in the report will allow you to identify three important factors in the market which are products, revenue, and growth profitability.
Request a Sample Copy: https://www.worldwidemarketreports.com/sample/307299
Key Players Focused:
B.Braun (Germany) ,Boston Scientific (U.S.) ,Medtronic (U.S.) ,Cardinal Health…
